BDNF Release and Signaling Are Required for the Antidepressant Actions of GLYX-13

Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication

Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052 · see citing works

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,501 · see citing works

Translational Findings on Brain-Derived Neurotrophic Factor and Anxiety: Contributions from Basic Research to Clinical Practice

da Luz, A. C. D. D. S., Dias, G. P., Bevilaqua, M. C. D. N., Cocks, G. D., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 4,012 · see citing works

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · see citing works

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · see citing works

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · see citing works

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · see citing works

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · see citing works

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · see citing works

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · see citing works

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression

Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654 · see citing works

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609 · see citing works

Diagnosis and definition of treatment-resistant depression

Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380 · see citing works

Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior

Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., et al. (2006) · Science · doi:10.1126/science.1129663 · Cited by 1,340 · see citing works

Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure

Li, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082 · see citing works

Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design

Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076 · see citing works

RHO GTPASES in neuronal morphogenesis

Luo, L. (2000) · Nature reviews. Neuroscience · doi:10.1038/35044547 · Cited by 985 · see citing works

Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia

Lahti, A. C., Koffel, B., LaPorte, D. J., & Tamminga, C. A. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00131-i · Cited by 921 · see citing works

Small GTPases Rac and Rho in the maintenance of dendritic spines and branches in hippocampal pyramidal neurons

Nakayama, A. Y., Harms, M. B., & Luo, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-14-05329.2000 · Cited by 708 · see citing works

Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics

Malhotra, A. K. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00036-5 · Cited by 681 · see citing works

Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics

Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-053013-062946 · Cited by 422 · see citing works

Regulation of Dendritic Spine Morphology by the Rho Family of Small GTPases: Antagonistic Roles of Rac and Rho

Tashiro, A. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.10.927 · Cited by 416 · see citing works

Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex

Liu, R.-J., Lee, F. S., Li, X.-Y., Bambico, F., Duman, R. S., & Aghajanian, G. K. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.030 · Cited by 403 · see citing works

BDNF release is required for the behavioral actions of ketamine

Lepack, A. E., Fuchikami, M., Dwyer, J. M., Banasr, M., & Duman, R. S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu033 · Cited by 368 · see citing works

High-Fat Diet Induced Anxiety and Anhedonia: Impact on Brain Homeostasis and Inflammation

Dutheil, S., Ota, K. T., Wohleb, E. S., Rasmussen, K., & Duman, R. S. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.357 · Cited by 355 · see citing works

Correlation between plasma levels of glutamate, alanine and serine with severity of depression

Mitani, H., Shirayama, Y., Yamada, T., Maeda, K., Ashby, C. R., & Kawahara, R. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.03.036 · Cited by 332 · see citing works

Autocrine BDNF-TrkB signalling within a single dendritic spine

Harward, S. C., Hedrick, N. G., Hall, C. E., Parra-Bueno, P., Milner, T. A., Pan, E., Laviv, T., Hempstead, B. L., Yasuda, R., & McNamara, J. O. (2016) · Nature · doi:10.1038/nature19766 · Cited by 325 · see citing works

Interaction between stress and the BDNFVal66Met polymorphism in depression: a systematic review and meta-analysis

Hosang, G. M., Shiles, C., Tansey, K. E., McGuffin, P., & Uher, R. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-7 · Cited by 292 · see citing works

GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects

Burgdorf, J., Zhang, X.-L., Nicholson, K. L., Balster, R. L., David Leander, J., Stanton, P. K., Gross, A. L., Kroes, R. A., & Moskal, J. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.246 · Cited by 284 · see citing works

REDD1 is essential for stress-induced synaptic loss and depressive behavior

Ota, K. T., Liu, R.-J., Voleti, B., Maldonado-Aviles, J. G., Duric, V., Iwata, M., Dutheil, S., Duman, C., Boikess, S., Lewis, D. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3513 · Cited by 267 · see citing works

Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions

Fuchikami, M., Thomas, A., Liu, R., Wohleb, E. S., Land, B. B., DiLeone, R. J., Aghajanian, G. K., & Duman, R. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414728112 · Cited by 265 · see citing works

Plasma and platelet excitatory amino acids in psychiatric disorders

(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1731 · Cited by 243 · see citing works

Rho GTPase complementation underlies BDNF-dependent homo- and heterosynaptic plasticity

Hedrick, N. G., Harward, S. C., Hall, C. E., Murakoshi, H., McNamara, J. O., & Yasuda, R. (2016) · Nature · doi:10.1038/nature19784 · Cited by 240 · see citing works

Plasma and Platelet Amino Acid Concentrations in Patients Affected by Major Depression and under Fluvoxamine Treatment

Mauri, M. C., Ferrara, A., Boscati, L., Bravin, S., Zamberlan, F., Alecci, M., & INVERNIZZI, G. (1998) · Neuropsychobiology · doi:10.1159/000026491 · Cited by 231 · see citing works

Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA Translation

Jourdi, H., Hsu, Y.-T., Zhou, M., Qin, Q., Bi, X., & Baudry, M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6078-08.2009 · Cited by 226 · see citing works

Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients

Laje, G., Lally, N., Mathews, D., Brutsche, N., Chemerinski, A., Akula, N., Kelmendi, B., Simen, A., McMahon, F. J., Sanacora, G., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.031 · Cited by 213 · see citing works

Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent

PRESKORN, S., MACALUSO, M., MEHRA, D. V., ZAMMIT, G., MOSKAL, J. R., & BURCH, R. M. (2015) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000462606.17725.93 · Cited by 193 · see citing works

Fast-Acting Antidepressants Rapidly Stimulate ERK Signaling and BDNF Release in Primary Neuronal Cultures

Lepack, A. E., Bang, E., Lee, B., Dwyer, J. M., & Duman, R. S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.011 · Cited by 174 · see citing works

A hippocampal Cdk5 pathway regulates extinction of contextual fear

Sananbenesi, F., Fischer, A., Wang, X., Schrick, C., Neve, R. L., Radulović, J., & Tsai, L. (2007) · Nature Neuroscience · doi:10.1038/nn1943 · Cited by 141 · see citing works

Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors

Navarria, A., Wohleb, E. S., Voleti, B., Ota, K. T., Dutheil, S., Lepack, A. E., Dwyer, J. M., Fuchikami, M., Becker, A., Drago, F., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.012 · Cited by 118 · see citing works

A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral–CA1 synapses in hippocampus

Zhang, X.-L., Sullivan, J. A., Moskal, J. R., & Stanton, P. K. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.018 · Cited by 107 · see citing works

GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine

Liu, R.-J., Duman, C., Kato, T., Hare, B., Lopresto, D., Bang, E., Burgdorf, J., Moskal, J., Taylor, J., Aghajanian, G., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.202 · Cited by 105 · see citing works

GLYX-13: A monoclonal antibody-derived peptide that acts as an N-methyl-d-aspartate receptor modulator

Moskal, J. R., Kuo, A. G., Weiss, C., Wood, P. L., Hanson, A. O., Kelso, S. R., Harris, R. B., & Disterhoft, J. F. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.006 · Cited by 92 · see citing works

The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus

Burgdorf, J., Zhang, X.-L., Weiss, C., Gross, A., Boikess, S. R., Kroes, R. A., Khan, M. A., Burch, R. M., Rex, C. S., Disterhoft, J. F., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.004 · Cited by 88 · see citing works

A network map of BDNF/TRKB and BDNF/p75NTR signaling system

Sandhya, V. K., Raju, R., Verma, R., Advani, J., Sharma, R., Radhakrishnan, A., Nanjappa, V., Jayasuryan, N., Somani, B. L., Mukherjee, K. K., et al. (2013) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-013-0200-z · Cited by 88 · see citing works

AMPA receptor and GEF-H1/Lfc complex regulates dendritic spine development through RhoA signaling cascade

Kang, M.-G., Guo, Y., & Huganir, R. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812861106 · Cited by 82 · see citing works

Expression and Dendritic Trafficking of BDNF-6 Splice Variant are Impaired in Knock-In Mice Carrying Human BDNF Val66Met Polymorphism

Mallei, A., Baj, G., Ieraci, A., Corna, S., Musazzi, L., Lee, F. S., Tongiorgi, E., & Popoli, M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv069 · Cited by 61 · see citing works

Post-training activation of Rac1 in the basolateral amygdala is required for the formation of both short-term and long-term auditory fear memory

Gao, Q., Yao, W., Wang, J., Yang, T., Liu, C., Tao, Y., Chen, Y., Liu, X., & Ma, L. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00065 · Cited by 29 · see citing works

Implication of Rho‐associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats

Narita, M., Takagi, M., Aoki, K., Kuzumaki, N., & Suzuki, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01784.x · Cited by 25 · see citing works

Physiological pharmacokinetics and pharmacodynamics of (±)‐verapamil in female rats

Todd, E. L., & Abernethy, D. R. (1987) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510080309 · Cited by 17 · see citing works

Neuropsychological assessment and chronic schizophrenia.

Donnelly, E. F., Waldman, I. N., Reider, R., & Weinberger, D. R. (1980) · PubMed · Cited by 7 · see citing works

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

Duman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026 · see citing works

Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer

Colucci-D’Amato, L., Speranza, L., & Volpicelli, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207777 · Cited by 991 · see citing works

Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions

Fogaça, M. V., & Duman, R. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00087 · Cited by 396 · see citing works

Role of BDNF in the Pathophysiology and Treatment of Depression: Activity-Dependent Effects Distinguish Rapid-Acting Antidepressants

Duman, R. S., Deyama, S., & Fogaça, M. V. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14630 · Cited by 321 · see citing works

The physiology of regulated BDNF release

Brigadski, T., & Leßmann, V. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03253-2 · Cited by 210 · see citing works

Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide

Duman, R. S. (2018) · F1000Research · doi:10.12688/f1000research.14344.1 · Cited by 208 · see citing works

Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2 <i>R</i> ,6 <i>R</i> )-hydroxynorketamine

Fukumoto, K., Fogaça, M. V., Liu, R.-J., Duman, C., Kato, T., Li, X.-Y., & Duman, R. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814709116 · Cited by 188 · see citing works

Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine

Deyama, S., & Duman, R. S. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172837 · Cited by 186 · see citing works

Convergent Mechanisms Underlying Rapid Antidepressant Action

Zanos, P., Thompson, S. M., Duman, R. S., Zarate, C. A., & Gould, T. D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0492-x · Cited by 171 · see citing works

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments

Kadriu, B., Musazzi, L., Henter, I. D., Graves, M., Popoli, M., & Zarate, C. A. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy094 · Cited by 165 · see citing works

Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function

Duman, R. S., Shinohara, R., Fogaça, M. V., & Hare, B. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0400-x · Cited by 154 · see citing works

Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants

Gould, T. D., Zarate, C. A., & Thompson, S. M. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052811 · Cited by 133 · see citing works

Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor

Deyama, S., Bang, E., Kato, T., Li, X.-Y., & Duman, R. S. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.12.014 · Cited by 116 · see citing works

Sestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation

Kato, T., Pothula, S., Liu, R.-J., Duman, C. H., Terwilliger, R., Vlasuk, G. P., Saiah, E., Hahm, S., & Duman, R. S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126859 · Cited by 88 · see citing works

Ketamine and the Future of Rapid-Acting Antidepressants

Riggs, L. M., & Gould, T. D. (2021) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-072120-014126 · Cited by 87 · see citing works

Cell-type specific modulation of NMDA receptors triggers antidepressant actions

Pothula, S., KATO, T., Liu, R.-J., Wu, M., Gerhard, D. M., Shinohara, R., Sliby, A., Chowdhury, G. M. I., Behar, K. L., Sanacora, G., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0796-3 · Cited by 81 · see citing works

N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects

Fogaça, M. V., Fukumoto, K., Franklin, T., Liu, R.-J., Duman, C. H., Vitolo, O. V., & Duman, R. S. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0501-x · Cited by 82 · see citing works

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets

Caraci, F., Calabrese, F., Molteni, R., Bartova, L., Dold, M., Leggio, G. M., Fabbri, C., Mendlewicz, J., Racagni, G., Kasper, S. F., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014977 · Cited by 73 · see citing works

Neurobiology of Depression: Chronic Stress Alters the Glutamatergic System in the Brain—Focusing on AMPA Receptor

Lee, M. T., Peng, W., Kan, H., Wu, C., Wang, D., & Ho, Y. (2022) · Biomedicines · doi:10.3390/biomedicines10051005 · Cited by 67 · see citing works

BDNF corrects NLRP3 inflammasome-induced pyroptosis and glucose metabolism reprogramming through KLF2/HK1 pathway in vascular endothelial cells

Jin, H. L., Zhu, Y., Wang, X.-D., Luo, E., Li, Y., Wang, B.-L., & Chen, Y. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109843 · Cited by 61 · see citing works

A Role of BDNF in the Depression Pathogenesis and a Potential Target as Antidepressant: The Modulator of Stress Sensitivity “Shati/Nat8l-BDNF System” in the Dorsal Striatum

Miyanishi, H., & Nitta, A. (2021) · Pharmaceuticals · doi:10.3390/ph14090889 · Cited by 57 · see citing works

The Neurotrophic Hypothesis of Depression Revisited: New Insights and Therapeutic Implications

Jaggar, M., Fanibunda, S. E., Ghosh, S. K., Duman, R. S., & Vaidya, V. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00006-8 · Cited by 58 · see citing works

Role of a VGF/BDNF/TrkB Autoregulatory Feedback Loop in Rapid-Acting Antidepressant Efficacy

Jiang, C. S., Lin, W., & Salton, S. R. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1124-0 · Cited by 55 · see citing works

Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation

Fukumoto, K., Fogaça, M. V., Liu, R.-J., Duman, C. H., Li, X., Chaki, S., & Duman, R. S. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0705-0 · Cited by 55 · see citing works

Neurobiology of the rapid-acting antidepressant effects of ketamine: impact and opportunities

Shinohara, R., Aghajanian, G. K., & Abdallah, C. G. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.12.006 · Cited by 54 · see citing works

Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant

Xu, S., Yao, X., Li, B., Cui, R., Zhu, C., Wang, Y., & Yang, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.740996 · Cited by 51 · see citing works

Isoflurane produces antidepressant effects inducing BDNF-TrkB signaling in CUMS mice

Zhang, S.-S., Tian, Y.-H., Jin, S.-J., Wang, W.-C., Zhao, J.-X., Si, X.-M., Zhang, L., Xu, H., & Jin, J.-Y. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05287-z · Cited by 49 · see citing works

Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms

KATO, T., & Duman, R. S. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172827 · Cited by 49 · see citing works

Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review

Pardossi, S., Fagiolini, A., & Cuomo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313098 · Cited by 51 · see citing works

Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine

Kohtala, S., Alitalo, O., Rosenholm, M., Rozov, S. V., & Rantamäki, T. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107741 · Cited by 46 · see citing works

Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants

Wang, Y., Zhang, N., Liu, L., Jiang, H., Hu, D., Wang, Z., Chen, N., & Zhang, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.024 · Cited by 46 · see citing works

Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine

Deyama, S., & Kaneda, K. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109335 · Cited by 46 · see citing works

VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine

Jiang, C., Lin, W.-J., Labonté, B., Tamminga, C. A., Turecki, G., Nestler, E. J., Russo, S. J., & Salton, S. R. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0277-4 · Cited by 43 · see citing works

Antidiabetic Drug Metformin Ameliorates Depressive-Like Behavior in Mice with Chronic Restraint Stress via Activation of AMP-Activated Protein Kinase

Ai, H., Fang, W., Hanyi, H., Xupang, H., & Lu, W. (2020) · Aging and Disease · doi:10.14336/ad.2019.0403 · Cited by 44 · see citing works

Ketamine Alleviates Postoperative Depression-Like Symptoms in Susceptible Mice: The Role of BDNF-TrkB Signaling

Li, S., Luo, X., Hua, D., Wang, Y., Zhan, G., Huang, N., Jiang, R., Yang, L., Zhu, B., Yuan, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01702 · Cited by 45 · see citing works

IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine

Deyama, S., Kondo, M., Shimada, S., & Kaneda, K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01943-9 · Cited by 43 · see citing works

Activation of astrocytic sigma‐1 receptor exerts antidepressant‐like effect via facilitating <scp>CD38</scp>‐driven mitochondria transfer

Wang, Y., Ni, J., Gao, T., Gao, C., Guo, L., & Yin, X. (2020) · Glia · doi:10.1002/glia.23850 · Cited by 42 · see citing works

Mechanism underlying NMDA blockade-induced inhibition of aggression in post-weaning socially isolated mice

Chang, C., Su, C.-L., & Gean, P. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.019 · Cited by 34 · see citing works

Exploring the association between BDNF related signaling pathways and depression: A literature review

Fan, Y., Luan, X., Wang, X., Li, H., Zhao, H., Li, S., Li, X., & Qiu, Z. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111143 · Cited by 35 · see citing works

Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date

Ragguett, R.-M., Rong, C., Kratiuk, K., & McIntyre, R. S. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1559295 · Cited by 30 · see citing works

The stress susceptibility factor FKBP51 controls S-ketamine-evoked release of mBDNF in the prefrontal cortex of mice

Anderzhanova, E., Hafner, K., Genewsky, A. J., Soliman, A., Pöhlmann, M. L., Schmidt, M. V., Blum, R., Wotjak, C. T., & Gassen, N. C. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100239 · Cited by 29 · see citing works

M1 acetylcholine receptors in somatostatin interneurons contribute to GABAergic and glutamatergic plasticity in the mPFC and antidepressant-like responses

Fogaça, M. V., Wu, M., Li, C., Li, X., Duman, R. S., & Picciotto, M. R. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01583-7 · Cited by 28 · see citing works

Sigma-1 receptor activation mediates the sustained antidepressant effect of ketamine in mice via increasing BDNF levels

Ma, H., Li, J., Qiao, X., Zhang, Y., Hou, X.-J., Chen, H., Chen, H., Zhang, Y., & Li, Y. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01201-8 · Cited by 28 · see citing works

Activation of neuronal Ras‐related C3 botulinum toxin substrate 1 (Rac1) improves post‐stroke recovery and axonal plasticity in mice

Bu, F., Munshi, Y., Furr, J. W., Min, J., Li, Q., Patrizz, A., Spahr, Z. R., Urayama, A., Kofler, J., McCullough, L. D., et al. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15195 · Cited by 24 · see citing works

Contribution of DNA methyltransferases to spared nerve injury induced depression partially through epigenetically repressing Bdnf in hippocampus: Reversal by ketamine

Liu, R., Wu, X., He, X., Wang, R.-Z., Yin, X., Zhou, F., Ji, M., & Shen, J.-C. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173079 · Cited by 24 · see citing works

Role of mTOR1 signaling in the antidepressant effects of ketamine and the potential of mTORC1 activators as novel antidepressants

KATO, T. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109325 · Cited by 24 · see citing works

All roads lead to glutamate: NMDA and AMPA receptors as targets for rapid-acting antidepressants

Freudenberg, F., Reif-Leonhard, C., Dawson, G. R., McKernan, R. M., & Reif, A. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107918 · Cited by 23 · see citing works

KLF2 mediates the suppressive effect of BDNF on diabetic intimal calcification by inhibiting HK1 induced endothelial-to-mesenchymal transition

Wang, F., Zhang, J., Ji, Y., Yan, X.-J., Sun, L. V., Zhu, Y., & Jin, H. L. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110324 · Cited by 22 · see citing works

NMDA receptor partial agonist GLYX-13 alleviates chronic stress-induced depression-like behavior through enhancement of AMPA receptor function in the periaqueductal gray

Yang, P.-S., Peng, H., Lin, T.-B., Hsieh, M., Lai, C., Lee, A., Wang, H.-H., & Ho, Y. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108269 · Cited by 21 · see citing works

Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex

Deyama, S., Aoki, S., Sugie, R., Fukuda, H., Shuto, S., Minami, M., & Kaneda, K. (2023) · Neurotherapeutics · doi:10.1007/s13311-022-01337-1 · Cited by 18 · see citing works

The duration of the antidepressant-like effects of a single infusion of brain-derived neurotrophic factor into the medial prefrontal cortex in mice

Deyama, S., & Kaneda, K. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112844 · Cited by 18 · see citing works

Resolvins as potential candidates for the treatment of major depressive disorder

Deyama, S., Minami, M., & Kaneda, K. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.05.002 · Cited by 18 · see citing works

Mechanisms underlying the rapid-acting antidepressant-like effects of neuropeptide VGF (non-acronymic) C-terminal peptide TLQP-62

Lv, D., Chen, Y., Shen, M., Liu, X., Zhang, Y., Xu, J., & Wang, C. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.046 · Cited by 18 · see citing works

Differential Association of Serum BDNF With Poststroke Depression and Poststroke Anxiety

Han, Z., Wang, Y., Qi, L., Wang, J., Wong, J. W., Chen, J., Luo, X., & Wang, Q. M. (2020) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2020.04.011 · Cited by 16 · see citing works

Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor

Donello, J. E., McIntyre, R. S., Pickel, D. B., & Stahl, S. M. (2025) · Pharmaceuticals · doi:10.3390/ph18020157 · Cited by 15 · see citing works

Acute administration of ketamine attenuates the impairment of social behaviors induced by social defeat stress exposure as juveniles via activation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors

Hasegawa, S., Yoshimi, A., Mouri, A., Uchida, Y., Hida, H., Mishina, M., Yamada, K., Ozaki, N., Nabeshima, T., & Noda, Y. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.020 · Cited by 15 · see citing works

Targeting the dysfunction of glutamate receptors for the development of novel antidepressants

Xia, C., He, J., Du, L., Yan, Y., Lian, W., Xu, J., & Zhang, W. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107875 · Cited by 14 · see citing works

Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmission

Widman, A. J., & McMahon, L. L. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.05.001 · Cited by 13 · see citing works

Fluoroethylnormemantine, A Novel Derivative of Memantine, Facilitates Extinction Learning Without Sensorimotor Deficits

Chen, B. K., Pen, G. L., Eckmier, A., Rubinstenn, G., Jay, T. M., & Denny, C. A. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab007 · Cited by 14 · see citing works

The Cutting Edge Research of Functional Gastrointestinal Disorders in Japan: Review on JGA Core Symposium 2018–2020

Sugiyama, T., & Shiotani, A. (2020) · Digestion · doi:10.1159/000510680 · Cited by 13 · see citing works

Orexin A injection into the ventral medial prefrontal cortex induces antidepressant-like effects: Possible involvement of local Orexin-1 and Trk receptors

Stanquini, L. A., Sartim, A. G., & Joca, S. R. L. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112866 · Cited by 12 · see citing works

Research progress of non-monoamine antidepressants

Zhang, H., Wang, B., & Cao, X. (2021) · Stress and Brain · doi:10.26599/sab.2021.9060002 · Cited by 11 · see citing works

Rho GTPases in the Amygdala—A Switch for Fears?

Sarowar, T., & Grabrucker, A. M. (2020) · Cells · doi:10.3390/cells9091972 · Cited by 10 · see citing works

Ethanol and a rapid-acting antidepressant produce overlapping changes in exon expression in the synaptic transcriptome

Wolfe, S. A., Farris, S. P., Mayfield, J. E., Heaney, C. F., Erickson, E. K., Harris, R. A., Mayfield, R. D., & Raab‐Graham, K. F. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.007 · Cited by 11 · see citing works

HCN channels: New targets for the design of an antidepressant with rapid effects

Luo, P., He, G., & Liu, D. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.081 · Cited by 11 · see citing works

Basmisanil, an α5-GABAAR negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male mice

Daher, F., Villalobos, N. A., Hanley, M., Atack, J. R., Popa, M. O., & Fogaça, M. V. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137828 · Cited by 10 · see citing works

Positive Allosteric Modulation of AMPAR by PF-4778574 Produced Rapid Onset Antidepressant Actions in Mice

Shen, M., Lv, D., Li, S., Zhang, Y., Wang, Z., Zhao, C., Chen, X., & Wang, C. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy324 · Cited by 10 · see citing works

Influence of microbially fermented 2´-fucosyllactose on neuronal-like cell activity in an in vitro co-culture system

Kuntz, S., Kunz, C., Borsch, C., Hill, D. R., Morrin, S. T., Buck, R. H., & Rudloff, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1351433 · Cited by 9 · see citing works

The synergistic mechanism of action of Dajianzhong decoction in conjunction with ketamine in the treatment of depression

Li, C., Zhang, J., Liu, H., Yuan, H., Cai, J., Fogaça, M. V., & Zhang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115137 · Cited by 8 · see citing works

Underlying mechanisms of recombinant adeno-associated virus-mediated bicaudal C homolog 1 overexpression in the medial prefrontal cortex of mice with induced depressive-like behaviors

Wang, Z., Zhou, D., Li, S., Zhang, Y., & Wang, C. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.05.008 · Cited by 8 · see citing works

New advances in small molecule drugs targeting NMDA receptors

Zeng, Y., Qu, Z.-Y., Zhu, Q., Wang, H.-Y., Zhou, Y., & Gao, Z.-B. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01675-8 · Cited by 8 · see citing works

A novel NMDA receptor modulator: the antidepressant effect and mechanism of GW043

Tiliwaerde, M., Gao, N.-N., Yang, Y.-Q., & Jin, Z.-L. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14598 · Cited by 7 · see citing works

Stress Elicits Contrasting Effects on Rac1-Cofilin Signaling in the Hippocampus and Amygdala

Bose, M., Nawaz, M. S., Pal, R., & Chattarji, S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.880382 · Cited by 7 · see citing works

Microglia stimulation produces antidepressant-like effects in a mouse depression model induced by adolescent chronic unpredictable stress

Wang, H., Peng, J., Zhu, H., Sun, M., Fang, Y., Chen, Z., Hu, W., Tong, L., Ren, J., Huang, C., et al. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114782 · Cited by 5 · see citing works

Resolvins as novel targets for rapid-acting antidepressants

Deyama, S. (2020) · Folia Pharmacologica Japonica · doi:10.1254/fpj.20044 · Cited by 5 · see citing works

NMDAR modulators as rapid antidepressants: Converging and distinct signaling mechanisms

Lee, B., Pothula, S., & Duman, R. S. (2020) · Integrative Clinical Medicine · doi:10.15761/icm.1000173 · Cited by 5 · see citing works

Methylglyoxal modification of TrkB promotes synaptic plasticity and enhances resilience to chronic stressPreprint

Wu, Z., Fu, Y., Yang, Y., Huang, C., Zheng, C., Guo, Z., Yang, Z., Chen, X., Zhu, J., Wang, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/435867 · Cited by 5 · see citing works

Neuroprotective roles of neurotrophic growth factors in mood disorders

Jiang, C., & Salton, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814037-6.00010-0 · Cited by 5 · see citing works

Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder

Li, W., Liu, J., Fan, M., Li, Z., Chen, Y., Zhang, G., Huang, Z., & Zhang, L. (2018) · Molecules · doi:10.3390/molecules23050996 · Cited by 3 · see citing works

Current Glutamatergic Treatments and Future Directions for Glutamate-Based Management of Chronic Stress and Stress-Related Disorders

Coutellier, L. D., Musazzi, L., & Pavlovic, Z. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_4 · Cited by 2 · see citing works

Ketamine and epigenetic processes in depression, intersection between serotonergic and glutamatergic pathways

Nepton, A., Farahani, H., Williams, M. T., Booij, L., & Faber, S. C. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00343 · Cited by 2 · see citing works

(2R,6R)-Hydroxynorketamine, A Metabolite of Ketamine: The Antidepressant Actions and the Mechanisms

Fukumoto, K., & Duman, R. S. (2021) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-79790-4_2 · Cited by 1 · see citing works

Role of CaMKII/CREB pathway in rapid-antidepressant-like effect: comparison of ketamine with rapastinel

Özler, C., Özkan, E., Shomalizadeh, N., Kesibi, J., Sapancı, S., Akpunar, F., Uçar, E. A., & Özdemir, Y. (2025) · Experimental Brain Research · doi:10.1007/s00221-025-07085-w · Cited by 1 · see citing works

Negative allosteric modulation of α5-GABA A receptors engages dynamic cortical glutamatergic and GABAergic mechanisms underlying adaptive behavior in micePreprint

Daher, F., Fukushima, C. T., Ingebretsen, E. A., Bidlack, J. M., Atack, J. R., Popa, M. O., & Fogaça, M. V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.15.699507 · Cited by 1 · see citing works

Antidepressants: Pharmacology and Biochemistry

Efinger, V., Müller, W. E., & Friedland, K. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_26-1

Antidepressants: Pharmacology and Biochemistry

Efinger, V., Müller, W. E., & Friedland, K. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_26

Recent advances in rapid-acting antidepressants

Pan, L., He, Y., Wang, G., & Shen, J. (2025) · Scientia Sinica Chimica · doi:10.1360/ssc-2025-0157

Drugs under investigation for treatment-resistant depression

Costa, A. P., Machado‐Vieira, R., & Kaster, M. P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00034-7

GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine

Liu, R.-J., Duman, C., Kato, T., Hare, B., Lopresto, D., Bang, E., Burgdorf, J., Moskal, J., Taylor, J., Aghajanian, G., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.202 · Cited by 105 · see citing works

GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists

Moskal, J. R., Burch, R. M., Burgdorf, J. S., Kroes, R. A., Stanton, P. K., Disterhoft, J. F., & Leander, J. D. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.852536 · Cited by 130 · see citing works

NMDA receptor partial agonist GLYX-13 alleviates chronic stress-induced depression-like behavior through enhancement of AMPA receptor function in the periaqueductal gray

Yang, P.-S., Peng, H., Lin, T.-B., Hsieh, M., Lai, C., Lee, A., Wang, H.-H., & Ho, Y. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108269 · Cited by 21 · see citing works

GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects

Burgdorf, J., Zhang, X.-L., Nicholson, K. L., Balster, R. L., David Leander, J., Stanton, P. K., Gross, A. L., Kroes, R. A., & Moskal, J. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.246 · Cited by 284 · see citing works

Fast-Acting Antidepressants Rapidly Stimulate ERK Signaling and BDNF Release in Primary Neuronal Cultures

Lepack, A. E., Bang, E., Lee, B., Dwyer, J. M., & Duman, R. S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.011 · Cited by 174 · see citing works